- Report
- November 2024
- 77 Pages
Global
From €3500EUR$4,097USD£3,147GBP
- Report
- October 2024
- 180 Pages
Global
From €3244EUR$3,545USD£2,819GBP
€3605EUR$3,939USD£3,132GBP
- Report
- August 2024
- 164 Pages
Global
From €2288EUR$2,500USD£1,988GBP
- Report
- July 2024
- 150 Pages
Global
From €3432EUR$3,750USD£2,982GBP
- Report
- May 2024
- 200 Pages
Global
From €3798EUR$4,150USD£3,300GBP
- Report
- October 2024
- 128 Pages
Global
From €3660EUR$4,000USD£3,180GBP
- Report
- June 2023
- 1041 Pages
Europe
From €8231EUR$8,995USD£7,152GBP
The Endovascular Treatment Device market is a segment of the Medical Devices industry that focuses on the development and production of devices used to treat vascular diseases. These devices are typically minimally invasive and are used to diagnose, treat, and monitor vascular conditions. Common endovascular treatments include angioplasty, stenting, embolization, and thrombectomy. Endovascular treatments are often used to treat conditions such as peripheral artery disease, stroke, and aneurysms.
Endovascular Treatment Devices are typically made of biocompatible materials such as stainless steel, nitinol, and polymers. These devices are designed to be inserted into the body through a catheter and are often used in combination with imaging technologies such as X-ray, ultrasound, and CT scans.
Some of the major companies in the Endovascular Treatment Device market include Abbott, Boston Scientific, Medtronic, Johnson & Johnson, and Terumo. Show Less Read more